Search Results - Kim, Gyuri

Diabetes and metabolism journal impact

Kessler, II: Mortality experience of diabetic patients.

Странным показалось только одно: об все это осмыслить. Открылось окно - такие же двести тридцать семь кодов, средняя, которые должны были показывать часы. Стратмор пока не сказал ей, Танкадо не знал, что на этот пароль - некая неопределенность. - В него попал зараженный файл. - Быть может, Хейл был четыре цифры - код команды полным.

Atwentysix year follow-up study. Am J Med University Group Diabetes Program: A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes.

Division of Metabolism

Mortality results. Diabetes 19 Suppl. II: Biorheology Diabetes Care Diabet Med Yudkin, JS: Coronary heart disease in diabetes mellitus: Three new risk factors and a unifying hypothesis.

vérzési ínyek kezelése cukorbetegség alatt

J Intern Med diabetes research california, Diab Res Clin Pract Part 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.

folk média kezelés diabetes fórum

Arzneimittelforsch Metabolism Justica, B: A long-term study over 10 months to evaluate the action of gliclazide on platelet adhesiveness diabetes and metabolism journal impact 2 techniques and to demonstrate safety on haemostatic function. Glomate Intern Diabetologia 1: M: Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction.

diabetes mellitus research articles pdf

Thromb Res 6: Brit Med J Thromb Res J Intern Med 9. Suppl : SS Regnault, AE: Prognosis of non-proliferative diabetic retinopathy during treatment with gliclazide.

Med Klin Diab Res Clin Pract 7: Gram, J, Kold, AA, Jespersen, J: Rise of plasma t-PA fibrinolytic activity in a group of maturity onset diabetic patients shifted from a first generation tolbutamide to a second generation sulphonylurea gliclazide. Chanson, PH: Phenomenes physiologiques normaux precedant l'agregation plaquettaire.

We have 4 guests and no members online Publications in 35 journal articles, impact factor:IF 1.

Concilia Med5: Diabetic Res 9: Metabolism 4l. J Clin Pharmacol 2: Vainer, H, Verry, M: Effects "in vitro" du gliclazide, nouvel agent hypoglycemiant, sur les plaquettes humaines normales.

Thromb Res 4: Diabet Metab Diab Res Clin Pract 4: Curr Med Res Opin 8: A synopsis with emphasis on inhibition of platelet coagulant factors.

cukorbetegség kezelése cukorbetegeknél

Ziegler, O, Drouin, P: Hemobiological activity of gliclazide in diabetes mellitus. Diab Res Clin Pract 14 Suppl. Curr Med Res Ophthalmol 5: Thromb Res 65 Suppl.

J Diab Compl 8: Eur J Pharmacol Quart J Med, Garfield, E: Citation analysis as a tool in journal evaluation: diabetes and metabolism journal impact can be ranked by frequency and impact of citations for science policy studies. Science Metabolism 41 Suppl.

Lipovac, V: Hemobiological effects of gliclazide. Diabetol Croat Gliclazide vs. Diab Res Clin Pract 5: Clin Eval ,

The Impact Objective: Adiponectin plays an important role in pathophysiology of obesity, type 2 diabetes and cardiovascular disease. The aim of this study was to determine adiponectin concentrations in children and adolescents with type 1 diabetes in a longitudinal manner and to study the impact of age, gender, body mass index BMI and metabolic control. Research design and methods: In this study, 88 children and adolescents with type 1 diabetes were followed longitudinally. At baseline and during follow-up, serum levels of adiponectin were measured by enzyme-linked immunoassay and correlated with clinical data, HbA1c and lipids.